← All trials
NCT05289076
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 17, 2022
- Primary completion
- Mar 14, 2024
- Completion date
- Mar 14, 2025
- First posted
- Mar 21, 2022
- Last posted
- Dec 1, 2023
- Enrollment
- 40
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Linkoping UniversityLead sponsor
- Medical Research Council, SwedenCollaborator
- University of GothenburgCollaborator
- Linkoping UniversityReponsible party - principal investigator
- Linkoping UniversitySponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.